Form 4: Eli Lilly Director Acquires Shares Under Directors' Deferral Plan
SEC Form 4
Mary Lynne Hedley, a director at Eli Lilly & Co, acquired shares of common stock under the Lilly Directors' Deferral Plan.
Summary
- On April 21, 2025, Mary Lynne Hedley, a director of Eli Lilly & Co, acquired 12.123 shares of common stock at a price of $818.02 per share.
- These shares were acquired under the Lilly Directors' Deferral Plan in lieu of cash compensation and will be settled in shares of common stock following her separation from service.
- Following the transaction, Ms. Hedley directly owns 1,931.027 shares of Eli Lilly common stock.
- She also indirectly owns 98 shares through a trust, but disclaims beneficial ownership except to the extent of her pecuniary interest.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction indicating director's confidence, but it's not a major event.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The shares acquired will be settled in the future, following the reporting person's separation from service.
Industry Context
This is a routine disclosure related to insider transactions, which are common in publicly traded companies. Directors often receive stock as part of their compensation or participate in deferral plans.
Comparison to Industry Standards
- Director compensation packages often include stock options or deferred stock units to align their interests with shareholders, similar to practices at companies like Pfizer (PFE) and Johnson & Johnson (JNJ).
- Deferral plans are a common way for directors to manage their tax liabilities and retirement planning, aligning with industry norms.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 04/21/2025 | Date of transaction: Mary Lynne Hedley acquired shares of common stock. |
| 04/22/2025 | Date of signature: Report signed by Jonathan Groff on behalf of Mary Lynne Hedley. |
Keywords
Eli Lilly, Director, Share Acquisition, Directors' Deferral Plan, Common Stock, Hedley, LLY
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.